2011 Summit

Producing Sponsor

(joint with Nanotech 2006)

Jennifer Rocha
955 Massachusetts Ave. #313
Cambridge, MA 02139
Phone: (774) 249-8514

Location:	VA, US
Speaker:	C. P. Singh
Title:	President & CEO
Primary Industry:	Health & Medical Devices
Executive Summary:	Nano Interface Technology, Inc. (NITI) has developed nanotechnology-derived economical ultra-pure coatings for orthopedic and dental implants which FDA has been looking for many years. The NIH Nanotech review panel validates NITI’s proprietary technology by stating “Excellent quality of product and its enormous clinical benifits.” For the last 20 years, the lifespan of orthopedic and dental implants has been 10-12 years with revision rate of 17%. The ultra-pure (99+%) coatings developed by the NITI will increase the lifespan of these implants from 12 years to 20 years resulting in reduced revisions. It will also reduce the need of high strength painkillers. According to FDA report, current technology provides 30% - 66% pure coatings. Since this material is currently used in coatings of implants, therefore implants developed using this purer material will easily get the FDA approval without any clinical studies. The worldwide market size of the orthopedic and dental implants is $15B per year with 15% growth rate. The reduction in the revision rate of hip and knee implants from 17% to 12% has the potential of saving $ 832M per year in the US alone.
Venture is:	A-Round